State Street’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.81M | Sell |
2,860,124
-2,632,409
| -48% | -$7.19M | ﹤0.01% | 2736 |
|
|
2025
Q1 | $9.23M | Sell |
5,492,533
-1,217,128
| -18% | -$2.04M | ﹤0.01% | 2572 |
|
|
2024
Q4 | $10.9M | Buy |
6,709,661
+82,341
| +1% | +$134K | ﹤0.01% | 2579 |
|
|
2024
Q3 | $27.6M | Buy |
6,627,320
+269,274
| +4% | +$1.12M | ﹤0.01% | 2033 |
|
|
2024
Q2 | $34.7M | Sell |
6,358,046
-12,119
| -0.2% | -$66.2K | ﹤0.01% | 1844 |
|
|
2024
Q1 | $63.7M | Buy |
6,370,165
+461,478
| +8% | +$4.61M | ﹤0.01% | 1595 |
|
|
2023
Q4 | $24.1M | Buy |
5,908,687
+1,300,194
| +28% | +$5.3M | ﹤0.01% | 2113 |
|
|
2023
Q3 | $17.8M | Sell |
4,608,493
-229,310
| -5% | -$887K | ﹤0.01% | 2235 |
|
|
2023
Q2 | $28.8M | Sell |
4,837,803
-855,577
| -15% | -$5.1M | ﹤0.01% | 2006 |
|
|
2023
Q1 | $18.6M | Sell |
5,693,380
-1,095,371
| -16% | -$3.58M | ﹤0.01% | 2274 |
|
|
2022
Q4 | $26.8M | Buy |
6,788,751
+240,669
| +4% | +$951K | ﹤0.01% | 2035 |
|
|
2022
Q3 | $39.3M | Sell |
6,548,082
-2,046,331
| -24% | -$12.3M | ﹤0.01% | 1772 |
|
|
2022
Q2 | $55.3M | Buy |
8,594,413
+1,443,483
| +20% | +$9.28M | ﹤0.01% | 1574 |
|
|
2022
Q1 | $59.1M | Buy |
7,150,930
+3,614,591
| +102% | +$29.9M | ﹤0.01% | 1654 |
|
|
2021
Q4 | $54.7M | Buy |
3,536,339
+879,829
| +33% | +$13.6M | ﹤0.01% | 1743 |
|
|
2021
Q3 | $59.8M | Buy |
2,656,510
+680,068
| +34% | +$15.3M | ﹤0.01% | 1675 |
|
|
2021
Q2 | $38.9M | Buy |
1,976,442
+1,765,281
| +836% | +$34.7M | ﹤0.01% | 2035 |
|
|
2021
Q1 | $7.07M | Buy |
+211,161
| New | +$7.07M | ﹤0.01% | 2897 |
|